Age: 17.0
Sex: M
Vaccine: HPV4
Symptoms: Arthralgia, Arthritis, Back pain, Gait disturbance, Immunisation reaction
Clinical narrative: inflammatory seropositive rheumatoid arthritis/ difficulty walking in the morning and his wrists were swollen all day; joint pain involving his ankles, foot and lower back/ autoimmune disorder/ autoimmune injuries; Autonomic injuries; neurological injuries; This spontaneous report was received from a lawyer, regarding a case in litigation and refers to a male patient (pt), who was an adult at the time of report but whose age/age group at the time of events could not be established unequivocally. The pt's concurrent conditions, medical history or concurrent medications were not reported. On unknown dates, at the age of 17 years old, the pt was vaccinated with the first and second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (doses, routes of administration, anatomical locations, lot # and expiry dates were not provided) and on an unknown date, at the age of 18 years old, he received third dose (dose, route of administration, anatomical location, lot # and expiry date were not reported), all for prevention of cervical cancer (conflicting information as the pt was male), as consented by his mother and recommended by physician. The pt was a healthy, bright, active teenager prior to receiving quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). On unknown dates, the pt sustained serious autoimmune injuries and autonomic, and neurological injuries and resulting sequelae as a result of his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccinations. On unknown dates, following his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccinations, the pt had difficulty walking in the morning and his wrists were swollen all day. He suffered from joint pain involving his ankles, foot, and lower back. As the months progressed, so did the pt's symptoms. He was seen by multiple physicians and specialists for his complaints and prescribed medications to treat his symptoms. He did not know and had no reason to know that the symptoms he was experiencing were caused by the vaccine, as no information to the contrary was given to him by his medical providers. It was not until late 2021 that the pt began to suspect that quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was the cause of his symptoms and injuries. Based upon his chronic and severe post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was diagnosed with inflammatory seropositive rheumatoid arthritis. The pt contended that his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection(s) caused him to develop serious and debilitating autoimmune injuries, including but not limited to inflammatory seropositive rheumatoid arthritis, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), the pt suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and suffered severe and permanent emotional injuries, including pain and suffering. The pt also had a substantial fear of suffering additional and ongoing harms, including but not limited to being at an increased risk of cancer, and future symptoms and charms associated with his injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, he had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and he would continue to incur these losses and expenses in the future. The outcome of the events was considered to be not recovered. The relatedness between the events and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was considered to be related.  The reporter considered all events to be disabling. The events of seropositive rheumatoid arthritis and autonomic injuries were considered to be medically significant.